74197-21-0 Usage
Uses
Used in Pharmaceutical Industry:
4,5,6,7-tetrahydro-1H-indazol-6-aMine is utilized as a building block for the synthesis of pharmaceuticals. Its distinctive structure allows it to be a key component in the development of new drugs, contributing to drug discovery and the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4,5,6,7-tetrahydro-1H-indazol-6-aMine serves as a fundamental component in the creation of agrochemicals. Its role in this industry is crucial for the synthesis of compounds that can be used in various agricultural applications, such as pest control and crop protection.
Used in Organic Chemistry:
4,5,6,7-tetrahydro-1H-indazol-6-aMine is employed as a versatile building block in organic chemistry. Its unique properties make it suitable for use in a wide range of chemical reactions, facilitating the synthesis of various biologically active molecules.
Used in Coordination Chemistry:
As a ligand in coordination chemistry, 4,5,6,7-tetrahydro-1H-indazol-6-aMine plays a significant role in the formation of coordination compounds. Its ability to bind with metal ions allows it to be used in the development of new materials with potential applications in various fields, including catalysis and sensing.
Check Digit Verification of cas no
The CAS Registry Mumber 74197-21-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,1,9 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 74197-21:
(7*7)+(6*4)+(5*1)+(4*9)+(3*7)+(2*2)+(1*1)=140
140 % 10 = 0
So 74197-21-0 is a valid CAS Registry Number.
74197-21-0Relevant academic research and scientific papers
CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1
-
, (2009/05/29)
The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compound
